Author

Noelia Mayor-Garnacho

University of Castilla-La ManchaORCID 0009-0004-8762-4533Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

António FernándeziD· 1 shared Borja BelandiaiD· 1 shared Cristina Garnés‐GarcíaiD· 1 shared Diego M. Fernández‐ArocaiD· 1 shared Francisco J. CimasiD· 1 shared María José Ruiz‐HidalgoiD· 1 shared Pablo Fernández‐ArocaiD· 1 shared Ricardo Sánchez‐PrietoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

António FernándezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Revisiting AXL as a therapeutic target in soft tissue sarcoma: transcriptomic profiling reveals largely AXL-independent activity of dubermatinib and bemcentinib

Cristina Garnés‐García, Pablo Fernández‐Aroca, Francisco J. Cimas, María José Ruiz‐Hidalgo, Borja Belandia, Noelia Mayor-Garnacho, António Fernández, Victor Javier Sanchez-Arevalo Lobo, Ricardo Sánchez‐Prieto, Diego M. Fernández‐Aroca

This study shows that AXL inhibitors dubermatinib and bemcentinib have antitumour effects in soft tissue sarcoma that are largely independent of AXL inhibition.

bioRxiv · Oct 15, 2026 · PreprintCancer Biology